PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:40 AM ET

Sponsor Check › Person

IC
No photo found yet (own website and image search run after this page is viewed)

Isaac Cheng

Named as an officer, director or promoter on SEC Form D filings · MA, NC · Jan 21, 2010 → Mar 27, 2026

7deals (issuers)
$167.6Mreported sold
137investors
30Form D filings
2010–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Isaac Cheng is listed as a director on 30 SEC Form D filings by 7 issuers between Jan 2010 and Mar 2026. Largest by amount reported sold: Apnimed, Inc. (Cambridge, MA — pharmaceuticals — 2022–2026; $79.7M reported sold to 14 investors), Amylyx Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2017–2020; $30M reported sold to 37 investors), Liquidia Technologies Inc (Morrisville, NC — biotechnology — 2010–2018; $25.5M reported sold to 11 investors), BIOSCALE INC (Lexington, MA — biotechnology — 2010–2013; $18.8M reported sold to 69 investors), Atreaon, Inc. (Newton Centre, MA — pharmaceuticals — 2011; $8M reported sold to 1 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $167.6M sold in total.

Listed alongside Barry Wohl (9 shared filings), Chris Dimitropoulos (9 shared filings), Dennis Molnar (9 shared filings), Joseph C. Avellone (9 shared filings), Lawrence G. Miller (9 shared filings) and 57 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Isaac. Each name links to their own page.

1 of the issuers belongs to the sponsor group Envisia Therapeutics (5 issuers, $71.8M reported sold, 2009–2021).

What this means A sponsor group is one team that sets up a new company for each deal. Envisia Therapeutics has 5 companies on file and $71.8M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 30 public filings for Isaac Cheng and found 19 differences, 4 worth asking the sponsor about: Amount sold went down between filings; 38% of the money raised went to insiders; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Isaac Cheng has not run yet — it is joining a line of 58,649 names; searches run around the clock at the hosts' allowed rate. Searched so far: 661 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Isaac Cheng..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for Isaac Cheng — 4 worth asking about (compared 30 filings on Oct 24, 2026)

Worth asking · Mar 6, 2012 – Feb 21, 2013

Amount sold went down between filings — BIOSCALE INC

The Mar 6, 2012 filing says $5,261,050 sold; the Feb 21, 2013 Form D/A says $3,827,004 sold — $1,434,046 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Mar 6, 2012 ↗Form D/A (later) · Feb 21, 2013 ↗BIOSCALE INC — PartnerFacts page ↗
Sources
Worth asking · Dec 31, 2019

38% of the money raised went to insiders — Amylyx Pharmaceuticals, Inc.

The Dec 31, 2019 Form D/A reports $936,843 sold and $360,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Executive Compensation".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D/A · Dec 31, 2019 ↗Amylyx Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Dec 31, 2019

38% of the money raised went to insiders — Amylyx Pharmaceuticals, Inc.

The Dec 31, 2019 Form D reports $936,843 sold and $360,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Executive Compensation".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Dec 31, 2019 ↗Amylyx Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 26, 2011 – Jan 7, 2020

Isaac Cheng appears on 5 deals that stopped filing before reaching their target

Liquidia Technologies Inc (last filing Jan 7, 2020; $25,500,000 sold of $53,312,680); Torpedo Diagnostics, Inc. (last filing Jun 13, 2018; $2,000,000 sold of $5,200,000); SYNCHRONEURON INC. (last filing Jul 11, 2014; $3,500,054 sold of $19,999,992); BIOSCALE INC (last filing Jul 8, 2013; $18,838,559 sold of $38,341,397); Atreaon, Inc. (last filing Oct 26, 2011; $8,000,000 sold of $20,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Liquidia Technologies Inc — PartnerFacts page ↗Torpedo Diagnostics, Inc. — PartnerFacts page ↗SYNCHRONEURON INC. — PartnerFacts page ↗BIOSCALE INC — PartnerFacts page ↗
Sources
Note · Jan 25, 2013 – Mar 27, 2026

4 Form Ds were filed more than 15 days after the first sale

Form D filed 16 days after the first sale — Apnimed, Inc. · Form D filed 18 days after the first sale — Liquidia Technologies Inc · Form D filed 17 days after the first sale — BIOSCALE INC · Form D filed 45 days after the first sale — BIOSCALE INC

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Mar 27, 2026 ↗Apnimed, Inc. — PartnerFacts page ↗Form D · Feb 20, 2018 ↗Liquidia Technologies Inc — PartnerFacts page ↗
Sources
Note · May 28, 2010 – Nov 8, 2023

12 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Apnimed, Inc. (latest filing Nov 8, 2023) · No amendment in the last 12 months on an offering that may still be open — Amylyx Pharmaceuticals, Inc. (latest filing Jan 28, 2020) · No amendment in the last 12 months on an offering that may still be open — Torpedo Diagnostics, Inc. (latest filing Jun 13, 2018) · No amendment in the last 12 months on an offering that may still be open — Liquidia Technologies Inc (latest filing Feb 20, 2018) · No amendment in the last 12 months on an offering that may still be open — Amylyx Pharmaceuticals, Inc. (latest filing Aug 4, 2017) · and 7 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Nov 8, 2023 ↗Apnimed, Inc. — PartnerFacts page ↗Form D/A · Jan 28, 2020 ↗Amylyx Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jul 15, 2009 – Oct 1, 2025

6 offerings changed their target amount between filings

Offering amount changed between filings — Apnimed, Inc. · Offering amount changed between filings — Amylyx Pharmaceuticals, Inc. · Offering amount changed between filings — BIOSCALE INC · Offering amount changed between filings — Liquidia Technologies Inc · Offering amount changed between filings — Liquidia Technologies Inc · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Sep 24, 2025 ↗Form D/A (later) · Oct 1, 2025 ↗Apnimed, Inc. — PartnerFacts page ↗Form D/A (earlier) · Dec 31, 2019 ↗
Sources
Note · Jan 21, 2010 – Feb 21, 2013

Isaac Cheng is written 2 different ways on the filings

listed as "Isaac Cheng" on 29 filings (from Jan 21, 2010), and "Isaac S. Cheng" on the Feb 21, 2013 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D/A · Jan 21, 2010 ↗Form D/A · Feb 21, 2013 ↗Isaac Cheng — PartnerFacts page ↗
Sources
Note · Feb 16, 2012 – Jul 11, 2014

Industry group changed between filings — SYNCHRONEURON INC.

"Pharmaceuticals" (Feb 16, 2012); then "Other Health Care" (Jul 11, 2014).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Feb 16, 2012 ↗Form D · Jul 11, 2014 ↗SYNCHRONEURON INC. — PartnerFacts page ↗
Sources
Note · Jul 15, 2009 – Jul 2, 2012

Industry group changed between filings — Liquidia Technologies Inc

"Other" (Jul 15, 2009 to Mar 3, 2011); then "Biotechnology" (Jul 2, 2012 to Feb 20, 2018).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 15, 2009 ↗Form D/A · Jul 2, 2012 ↗Liquidia Technologies Inc — PartnerFacts page ↗
Sources
Note · Jul 15, 2009 – Feb 20, 2018

Reported revenue range changed between filings — Liquidia Technologies Inc

"Decline to Disclose" (Jul 15, 2009); then "$5,000,001 - $25,000,000" (Feb 20, 2018).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 15, 2009 ↗Form D · Feb 20, 2018 ↗Liquidia Technologies Inc — PartnerFacts page ↗
Sources
Note · Jan 9, 2024 – Oct 13, 2026

Same name, different state: "Isaac Cheng" (ME) is a separate record

This page covers filings where the address state is MA or NC. A separate record, "Isaac Cheng" with address state ME, is listed on 5 filings — most recently by MedRhythms, Inc. (Oct 13, 2026). Both records have filings in the same period (Jan 9, 2024 to Mar 27, 2026).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Isaac Cheng (ME) — PartnerFacts page ↗Form D · Oct 13, 2026 ↗MedRhythms, Inc. — PartnerFacts page ↗Isaac Cheng (MA,NC) — this page ↗
Sources
Note · Aug 31, 2011 – Jul 22, 2021

Same name, different state: "Isaac Cheng" (CA) is a separate record

This page covers filings where the address state is MA or NC. A separate record, "Isaac Cheng" with address state CA, is listed on 6 filings — most recently by Tallac Therapeutics, Inc. (Jul 22, 2021). Both records have filings in the same period (Aug 31, 2011 to Jul 22, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Isaac Cheng (CA) — PartnerFacts page ↗Form D/A · Jul 22, 2021 ↗Tallac Therapeutics, Inc. — PartnerFacts page ↗Isaac Cheng (MA,NC) — this page ↗
Sources
Note · Nov 22, 2019

Same name, different state: "Isaac Cheng" (NV or NE) is a separate record

This page covers filings where the address state is MA or NC. A separate record, "Isaac Cheng" with address state NV or NE, is listed on 2 filings — most recently by Adjuvance Technologies Inc. (Nov 22, 2019). Both records have filings in the same period (Nov 22, 2019).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Isaac Cheng (NV,NE) — PartnerFacts page ↗Form D/A · Nov 22, 2019 ↗Adjuvance Technologies Inc. — PartnerFacts page ↗Isaac Cheng (MA,NC) — this page ↗
Sources
Note · Sep 25, 2018

Same name, different state: "Isaac Cheng" (O9) is a separate record

This page covers filings where the address state is MA or NC. A separate record, "Isaac Cheng" with address state O9, is listed on 1 filing — most recently by DNATRIX INC (Sep 25, 2018). Both records have filings in the same period (Sep 25, 2018).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Isaac Cheng (O9) — PartnerFacts page ↗Form D · Sep 25, 2018 ↗DNATRIX INC — PartnerFacts page ↗Isaac Cheng (MA,NC) — this page ↗
Sources
Note · Aug 16, 2017 – Jun 13, 2018

Address moved from Cambridge, MA to Charlestown, MA — Torpedo Diagnostics, Inc.

The people listed on the Aug 16, 2017 filing give Cambridge, MA; on the Jun 13, 2018 filing they give Charlestown, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D/A · Aug 16, 2017 ↗Form D · Jun 13, 2018 ↗Torpedo Diagnostics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 2, 2012 – Feb 20, 2018

Address moved from Durham, NC to Morrisville, NC — Liquidia Technologies Inc

The people listed on the Jul 2, 2012 filing give Durham, NC; on the Feb 20, 2018 filing they give Morrisville, NC.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D/A · Jul 2, 2012 ↗Form D · Feb 20, 2018 ↗Liquidia Technologies Inc — PartnerFacts page ↗
Sources
Note · Jun 11, 2010 – Mar 6, 2012

Address moved from Cambridge, MA to Lexington, MA — BIOSCALE INC

The people listed on the Jun 11, 2010 filing give Cambridge, MA; on the Mar 6, 2012 filing they give Lexington, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jun 11, 2010 ↗Form D · Mar 6, 2012 ↗BIOSCALE INC — PartnerFacts page ↗
Sources
Note · Jan 21, 2010 – Mar 27, 2026

Isaac Cheng is listed with 2 different address states: MA, NC

MA on 29 filings (Jan 21, 2010 to Mar 27, 2026); NC on 1 filing (Feb 20, 2018).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · Jan 21, 2010 ↗Form D · Feb 20, 2018 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 22 offerings report sales commissions; 1 reports finder's fees totalling $400,000; 5 report proceeds to related persons totalling $2,030,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 27, 2026 D
Apnimed, Inc.
File 021-578027
$0$0$0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
None listed on this filingEDGAR ↗
Dec 8, 2025 D/A
Apnimed, Inc.
File 021-558476
$0$0$0None listed on this filingEDGAR ↗
Apr 24, 2025 D
Apnimed, Inc.
File 021-544389
$0$0$0None listed on this filingEDGAR ↗
Nov 8, 2023 D
Apnimed, Inc.
File 021-496807
$0$0$0None listed on this filingEDGAR ↗
Dec 23, 2022 D
Apnimed, Inc.
File 021-468579
$0$0$0None listed on this filingEDGAR ↗
Nov 1, 2022 D/A
Apnimed, Inc.
File 021-445175
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2020 D
Amylyx Pharmaceuticals, Inc.
File 021-370064
$0$0$0 (est.)
Executive Compensation
None listed on this filingEDGAR ↗
Jan 28, 2020 D/A
Amylyx Pharmaceuticals, Inc.
File 021-356768
$0$0$360,000 (est.)
Executive Compensation
None listed on this filingEDGAR ↗
Nov 20, 2018 D
Amylyx Pharmaceuticals, Inc.
File 021-326193
$0$0$360,000 (est.)
Executive Compensation
None listed on this filingEDGAR ↗
Jun 13, 2018 D
Torpedo Diagnostics, Inc.
File 021-314530
$0$0$0None listed on this filingEDGAR ↗
Feb 20, 2018 D
Liquidia Technologies Inc
File 021-305952
$0$400,000$0
None other than executive officers in their roles as employees.
David B. Loucks BrokerCheck CRD 2593163 ↗
via Healthios Capital Markets, LLC (CRD 115542 ↗)
EDGAR ↗
Aug 16, 2017 D/A
Torpedo Diagnostics, Inc.
File 021-292902
$0$0$0None listed on this filingEDGAR ↗
Aug 4, 2017 D
Amylyx Pharmaceuticals, Inc.
File 021-292155
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 11, 2014 D
SYNCHRONEURON INC.
File 021-220786
$0$0$0None listed on this filingEDGAR ↗
Jul 8, 2013 D
BIOSCALE INC
File 021-199127
$0$0$0None listed on this filingEDGAR ↗
Mar 11, 2013 D
BIOSCALE INC
File 021-193067
$0$0$0None listed on this filingEDGAR ↗
Feb 21, 2013 D/A
BIOSCALE INC
File 021-174397
$0$0$0None listed on this filingEDGAR ↗
Jul 2, 2012 D/A
Liquidia Technologies Inc
File 021-156174
$0$0$480,000 (est.)None listed on this filingEDGAR ↗
Feb 16, 2012 D
SYNCHRONEURON INC.
File 021-173596
$0$0$180,000None listed on this filingEDGAR ↗
Oct 26, 2011 D
Atreaon, Inc.
File 021-167827
$0$0$0None listed on this filingEDGAR ↗
Jun 11, 2010 D
BIOSCALE INC
File 021-143335
$0$0$0None listed on this filingEDGAR ↗
May 25, 2010 D/A
Liquidia Technologies Inc
File 021-78167
$0$0$650,000 (est.)None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Isaac Cheng on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

A
Pharmaceuticals

Apnimed, Inc.

Cambridge, MA · May 10, 2022 → Mar 27, 2026 · 9 filings
  • Mar 27, 2026 · D · $24,999,994 sold of $24,999,994 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 8, 2025 · D/A · $35,000,000 sold of $35,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 1, 2025 · D/A · $35,000,000 sold of $35,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 24, 2025 · D · $23,000,000 sold of $23,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 24, 2025 · D · $16,499,982 sold of $16,499,982 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 8, 2023 · D · $0 sold of $37,499,980 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 23, 2022 · D · $79,749,950 sold of $79,749,950 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 1, 2022 · D/A · $62,499,913 sold of $62,499,913 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 10, 2022 · D · $37,499,995 sold of $62,499,913 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $79.7M from 14 investors (100% of the $25M target) as of the latest filing. Isaac is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals

Amylyx Pharmaceuticals, Inc.

Cambridge, MA · Aug 4, 2017 → Jul 1, 2020 · 6 filings
  • Jul 1, 2020 · D · $30,000,000 sold of $30,000,000 · 17 investors · min. $10,000 · role: Director EDGAR ↗
  • Jan 28, 2020 · D/A · $14,773,328 sold of $20,000,000 · 37 investors · min. $10,000 · role: Director EDGAR ↗
  • Dec 31, 2019 · D/A · $936,843 sold of $15,000,000 · 8 investors · min. $10,000 · role: Director EDGAR ↗
  • Dec 31, 2019 · D · $936,843 sold of $15,000,000 · 8 investors · min. $10,000 · role: Director EDGAR ↗
  • Nov 20, 2018 · D · $12,978,100 sold of $12,978,100 · 32 investors · min. $10,000 · role: Director EDGAR ↗
  • Aug 4, 2017 · D · $1,832,698 sold of $2,342,698 · 30 investors · min. $2,372 · role: Director EDGAR ↗

Raised $30M from 37 investors (100% of the $30M target) as of the latest filing. Isaac is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TD
Biotechnology

Torpedo Diagnostics, Inc.

Charlestown, MA · Aug 16, 2017 → Jun 13, 2018 · 2 filings
  • Jun 13, 2018 · D · $2,000,000 sold of $5,200,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 16, 2017 · D/A · $2,000,000 sold of $2,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2M from 4 investors (38% of the $5.2M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LT
Biotechnology · group: Envisia Therapeutics

Liquidia Technologies Inc

Morrisville, NC · Jan 21, 2010 → Feb 20, 2018 · 5 filings
  • Feb 20, 2018 · D · $25,500,000 sold of $53,312,680 · 7 investors · min. $1 · role: Director EDGAR ↗
  • Jul 2, 2012 · D/A · $13,799,994 sold of $13,799,994 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 3, 2011 · D · $10,000,000 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 25, 2010 · D/A · $25,000,010 sold of $25,000,010 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 21, 2010 · D/A · $20,000,003 sold of $20,000,003 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.5M from 11 investors (48% of the $53.3M target) as of the latest filing. Isaac is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other Health Care

SYNCHRONEURON INC.

Waltham, MA · Feb 16, 2012 → Jul 11, 2014 · 2 filings
  • Jul 11, 2014 · D · $3,500,054 sold of $19,999,992 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 16, 2012 · D · $1,999,992 sold of $5,999,975 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.5M from 1 investor (18% of the $20M target) as of the latest filing. Isaac is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Biotechnology

BIOSCALE INC

Lexington, MA · Jun 11, 2010 → Jul 8, 2013 · 5 filings
  • Jul 8, 2013 · D · $18,838,559 sold of $38,341,397 · 69 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 11, 2013 · D · $1,062,028 sold of $5,097,733 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 21, 2013 · D/A · $3,827,004 sold of $10,690,400 · 62 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 6, 2012 · D · $5,261,050 sold of $10,522,100 · 37 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 11, 2010 · D · $15,672,158 sold of $25,000,000 · 42 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18.8M from 69 investors (49% of the $38.3M target) as of the latest filing. Isaac is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

A
Pharmaceuticals

Atreaon, Inc.

Newton Centre, MA · Oct 26, 2011
  • Oct 26, 2011 · D · $8,000,000 sold of $20,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8M from 1 investor (40% of the $20M target) as of the latest filing. Isaac is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (4)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Isaac Cheng — CA, 4 issuers, Aug 31, 2011 → Jul 22, 2021 · no shared issuer
  • Isaac Cheng — Monaco (as filed: O9), 1 issuer, Sep 25, 2018 → Sep 25, 2018 · no shared issuer
  • Isaac Cheng — NV, NE, 1 issuer, Nov 22, 2019 → Nov 22, 2019 · no shared issuer
  • Isaac Cheng — ME, 1 issuer, Jan 9, 2024 → Oct 13, 2026 · no shared issuer

People around Isaac 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Molnar

Executive Officer, Director · 9 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

BW
No photo found yet (own website and image search run after this page is viewed)
Person

Barry Wohl

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence G. Miller

Executive Officer, Director · 9 shared filings (1 issuer) · also on 6 other issuers

Lawrence G. Miller is on 7 issuers in total — a repeat sponsor. Their page lists every one.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph C. Avellone

Director · 9 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Dimitropoulos

Director · 9 shared filings (1 issuer) · also on 4 other issuers

Chris Dimitropoulos is on 5 issuers in total — a repeat sponsor. Their page lists every one.

FB
No photo found yet (own website and image search run after this page is viewed)
Person

Francois Beaubien

Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

PF
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Fonteyne

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

PF
No photo found yet (own website and image search run after this page is viewed)
Person

Peter B. Finn

Executive Officer · 6 shared filings (1 issuer) · also on 15 other issuers

Peter B. Finn is on 16 issuers in total — a repeat sponsor. Their page lists every one.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

George Milne

Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Chubb

Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Joshua Cohen

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Justin Klee

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

Walter Gilbert

Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Felix Von Coerper

Director · 6 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

KL
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Lind

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Sender

Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Crawley

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Seth Rudnick

Director · 5 shared filings (1 issuer) · also on 5 other issuers

Seth Rudnick is on 6 issuers in total — a repeat sponsor. Their page lists every one.

NF
No photo found yet (own website and image search run after this page is viewed)
Person

Neal Fowler

Executive Officer, Director · 5 shared filings (1 issuer) · also on 4 other issuers

Neal Fowler is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

Bard J. Geesaman

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ralph Snyderman

Director · 5 shared filings (1 issuer) · also on 5 other issuers

Ralph Snyderman is on 6 issuers in total — a repeat sponsor. Their page lists every one.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Lundstrom

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Ramzi Benamar

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Somu Subramaniam

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Boucher

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph DeSimone

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

CL
No photo found yet (own website and image search run after this page is viewed)
Person

Chip Leveille

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Brett Masters

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Ed Mathers

Director · 4 shared filings (1 issuer) · also on 12 other issuers

Ed Mathers is on 13 issuers in total — a repeat sponsor. Their page lists every one.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Rogers

Executive Officer · 4 shared filings (1 issuer) · also on 4 other issuers

Michael Rogers is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Riccardo Pigliucci

Director · 3 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

Dr. Martin Latterich

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Stefan Larson

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

SN
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Nelson

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

Gerald Chan

Director · 2 shared filings (1 issuer) · also on 10 other issuers

Gerald Chan is on 11 issuers in total — a repeat sponsor. Their page lists every one.

BF
No photo found yet (own website and image search run after this page is viewed)
Person

Barry S. Fogel

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

Bill Doyle

Director · 2 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

MARC R. COTE

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Scalzulli

Director · 2 shared filings (1 issuer)

Listed on the same filings as Isaac Cheng. Their page shows their other deals.

The team behind the deals

ET
Sponsor group

Envisia Therapeutics

5 issuers · 13 filings · $71.8M reported sold · 2009–2021

One team, 5 deal companies. Isaac Cheng is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Isaac Cheng.

Same business address

40 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 7 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Isaac Cheng by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Isaac Cheng is listed on: none on file. No website or social profile named in Apnimed, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #34,758 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗North Carolina eCourts portal ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗North Carolina Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Isaac Cheng appears on a new Form D, or when a court case or SEC action is matched to them. See plans →